Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Defining System Requirements for Simplified Blood Culture to Enable Widespread Use in Resource-Limited Settings.

Dailey PJ, Osborn J, Ashley EA, Baron EJ, Dance DAB, Fusco D, Fanello C, Manabe YC, Mokomane M, Newton PN, Tessema B, Isaacs C, Dittrich S.

Diagnostics (Basel). 2019 Jan 11;9(1). pii: E10. doi: 10.3390/diagnostics9010010.

2.

Assays for estimating HIV incidence: updated global market assessment and estimated economic value.

Morrison CS, Homan R, Mack N, Seepolmuang P, Averill M, Taylor J, Osborn J, Dailey P, Parkin N, Ongarello S, Mastro TD.

J Int AIDS Soc. 2017 Nov;20(3). doi: 10.1002/jia2.25018.

3.

Lung deposition and systemic bioavailability of different aerosol devices with and without humidification in mechanically ventilated patients.

Moustafa IOF, Ali MRA, Al Hallag M, Rabea H, Fink JB, Dailey P, Abdelrahim MEA.

Heart Lung. 2017 Nov - Dec;46(6):464-467. doi: 10.1016/j.hrtlng.2017.08.004. Epub 2017 Sep 4.

PMID:
28882385
4.

Patient Perceptions of Illness Identity in Cancer Clinical Trial Decision-Making.

Palmer-Wackerly AL, Dailey PM, Krok-Schoen JL, Rhodes ND, Krieger JL.

Health Commun. 2018 Aug;33(8):1045-1054. doi: 10.1080/10410236.2017.1331189. Epub 2017 Jun 16.

5.

Aerosol Delivery Through Adult High Flow Nasal Cannula With Heliox and Oxygen.

Dailey PA, Harwood R, Walsh K, Fink JB, Thayer T, Gagnon G, Ari A.

Respir Care. 2017 Sep;62(9):1186-1192. doi: 10.4187/respcare.05127. Epub 2017 Jun 6.

6.

Clinical outcome associated with the use of different inhalation method with and without humidification in asthmatic mechanically ventilated patients.

Moustafa IOF, ElHansy MHE, Al Hallag M, Fink JB, Dailey P, Rabea H, Abdelrahim MEA.

Pulm Pharmacol Ther. 2017 Aug;45:40-46. doi: 10.1016/j.pupt.2017.04.007. Epub 2017 Apr 20.

PMID:
28435031
7.

Moving towards a reliable HIV incidence test - current status, resources available, future directions and challenges ahead.

Murphy G, Pilcher CD, Keating SM, Kassanjee R, Facente SN, Welte A, Grebe E, Marson K, Busch MP, Dailey P, Parkin N, Osborn J, Ongarello S, Marsh K, Garcia-Calleja JM; Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA).

Epidemiol Infect. 2017 Apr;145(5):925-941. doi: 10.1017/S0950268816002910. Epub 2016 Dec 22. Review.

PMID:
28004622
8.

Distributed Cognition in Cancer Treatment Decision Making: An Application of the DECIDE Decision-Making Styles Typology.

Krieger JL, Krok-Schoen JL, Dailey PM, Palmer-Wackerly AL, Schoenberg N, Paskett ED, Dignan M.

Qual Health Res. 2017 Jul;27(8):1146-1159. doi: 10.1177/1049732316645321. Epub 2016 May 12.

9.

Age Differences in Cancer Treatment Decision Making and Social Support.

Krok-Schoen JL, Palmer-Wackerly AL, Dailey PM, Wojno JC, Krieger JL.

J Aging Health. 2017 Mar;29(2):187-205. doi: 10.1177/0898264316628488. Epub 2016 Jul 8.

10.

Communication and US-Somali Immigrant Human Papillomavirus (HPV) Vaccine Decision-Making.

Dailey PM, Krieger JL.

J Cancer Educ. 2017 Sep;32(3):516-521. doi: 10.1007/s13187-015-0959-0.

PMID:
26687173
11.

User Perceptions and Reactions to an Online Cancer Risk Assessment Tool: a Process Evaluation of Cancer Risk Check.

Hovick SR, Bevers TB, Vidrine JI, Kim S, Dailey PM, Jones LA, Peterson SK.

J Cancer Educ. 2017 Mar;32(1):141-147. doi: 10.1007/s13187-015-0939-4.

12.

Comprehension of Randomization and Uncertainty in Cancer Clinical Trials Decision Making Among Rural, Appalachian Patients.

Krieger JL, Palmer-Wackerly A, Dailey PM, Krok-Schoen JL, Schoenberg NE, Paskett ED.

J Cancer Educ. 2015 Dec;30(4):743-8. doi: 10.1007/s13187-015-0789-0.

13.

Community engagement as a process and an outcome of developing culturally grounded health communication interventions: an example from the DECIDE project.

Palmer-Wackerly AL, Krok JL, Dailey PM, Kight L, Krieger JL.

Am J Community Psychol. 2014 Jun;53(3-4):261-74. doi: 10.1007/s10464-013-9615-1.

14.

Optimization of microwave-enhanced methanolysis of algal biomass to biodiesel under temperature controlled conditions.

Patil P, Reddy H, Muppaneni T, Ponnusamy S, Sun Y, Dailey P, Cooke P, Patil U, Deng S.

Bioresour Technol. 2013 Jun;137:278-85. doi: 10.1016/j.biortech.2013.03.118. Epub 2013 Mar 27.

PMID:
23587830
15.

In vitro comparison of heliox and oxygen in aerosol delivery using pediatric high flow nasal cannula.

Ari A, Harwood R, Sheard M, Dailey P, Fink JB.

Pediatr Pulmonol. 2011 Aug;46(8):795-801. doi: 10.1002/ppul.21421. Epub 2011 Mar 24.

PMID:
21438178
16.

Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology.

Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K, Kop J, Owens MR, Rodgers R, Banada P, Safi H, Blakemore R, Lan NT, Jones-López EC, Levi M, Burday M, Ayakaka I, Mugerwa RD, McMillan B, Winn-Deen E, Christel L, Dailey P, Perkins MD, Persing DH, Alland D.

J Clin Microbiol. 2010 Jan;48(1):229-37. doi: 10.1128/JCM.01463-09. Epub 2009 Oct 28.

17.

Democratizing molecular diagnostics: the GeneXpert(®) enterovirus assay.

Patel SR, Weir F, Dailey P, Persing DH.

Expert Opin Med Diagn. 2009 Jan;3(1):91-7. doi: 10.1517/17530050802617307.

PMID:
23495966
18.

Chronic immune stimulation accelerates SIV-induced disease progression.

Villinger F, Rowe T, Parekh BS, Green TA, Mayne AE, Grimm B, McClure HM, Lackner AA, Dailey PJ, Ansari AA, Folks TM.

J Med Primatol. 2001 Oct;30(5):254-9.

PMID:
11990240
19.

The liver is a major organ for clearing simian immunodeficiency virus in rhesus monkeys.

Zhang L, Dailey PJ, Gettie A, Blanchard J, Ho DD.

J Virol. 2002 May;76(10):5271-3.

20.

Route of simian immunodeficiency virus inoculation determines the complexity but not the identity of viral variant populations that infect rhesus macaques.

Greenier JL, Miller CJ, Lu D, Dailey PJ, Lü FX, Kunstman KJ, Wolinsky SM, Marthas ML.

J Virol. 2001 Apr;75(8):3753-65.

21.

Simian immunodeficiency virus-specific cytotoxic T lymphocytes and cell-associated viral RNA levels in distinct lymphoid compartments of SIVmac-infected rhesus monkeys.

Kuroda MJ, Schmitz JE, Seth A, Veazey RS, Nickerson CE, Lifton MA, Dailey PJ, Forman MA, Racz P, Tenner-Racz K, Letvin NL.

Blood. 2000 Aug 15;96(4):1474-9.

22.

Antiviral treatment normalizes neurophysiological but not movement abnormalities in simian immunodeficiency virus-infected monkeys.

Fox HS, Weed MR, Huitron-Resendiz S, Baig J, Horn TF, Dailey PJ, Bischofberger N, Henriksen SJ.

J Clin Invest. 2000 Jul;106(1):37-45.

23.

Simian immunodeficiency virus (SIV)-specific CTL are present in large numbers in livers of SIV-infected rhesus monkeys.

Schmitz JE, Kuroda MJ, Veazey RS, Seth A, Taylor WM, Nickerson CE, Lifton MA, Dailey PJ, Forman MA, Racz P, Tenner-Racz K, Letvin NL.

J Immunol. 2000 Jun 1;164(11):6015-9.

24.

Prophylactic and therapeutic benefits of short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPA.

Van Rompay KK, Miller MD, Marthas ML, Margot NA, Dailey PJ, Canfield DR, Tarara RP, Cherrington JM, Aguirre NL, Bischofberger N, Pedersen NC.

J Virol. 2000 Feb;74(4):1767-74.

25.

Retrospective analysis of viral load and SIV antibody responses in rhesus macaques infected with pathogenic SIV: predictive value for disease progression.

Smith SM, Holland B, Russo C, Dailey PJ, Marx PA, Connor RI.

AIDS Res Hum Retroviruses. 1999 Dec 10;15(18):1691-701.

PMID:
10606092
26.

Induction of mucosal antibody responses by microsphere-encapsulated formalin-inactivated simian immunodeficiency virus in a male urethral challenge model.

Ishizaka ST, Israel ZR, Gettie A, Mishkin EM, Staas JK, Gilley RM, Dailey PJ, Montefiori DC, Marx PA, Eldridge JH.

Vaccine. 1999 Jul 16;17(22):2817-25.

PMID:
10438051
28.

Simian immunodeficiency virus disease course is predicted by the extent of virus replication during primary infection.

Staprans SI, Dailey PJ, Rosenthal A, Horton C, Grant RM, Lerche N, Feinberg MB.

J Virol. 1999 Jun;73(6):4829-39.

29.

Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression.

Kimata JT, Kuller L, Anderson DB, Dailey P, Overbaugh J.

Nat Med. 1999 May;5(5):535-41.

PMID:
10229230
30.

9-[2-(Phosphonomethoxy)propyl]adenine (PMPA) therapy prolongs survival of infant macaques inoculated with simian immunodeficiency virus with reduced susceptibility to PMPA.

Van Rompay KK, Cherrington JM, Marthas ML, Lamy PD, Dailey PJ, Canfield DR, Tarara RP, Bischofberger N, Pedersen NC.

Antimicrob Agents Chemother. 1999 Apr;43(4):802-12.

31.

Viral burden and disease progression in rhesus monkeys infected with chimeric simian-human immunodeficiency viruses.

Reimann KA, Watson A, Dailey PJ, Lin W, Lord CI, Steenbeke TD, Parker RA, Axthelm MK, Karlsson GB.

Virology. 1999 Mar 30;256(1):15-21.

32.

Early short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine treatment favorably alters the subsequent disease course in simian immunodeficiency virus-infected newborn Rhesus macaques.

van Rompay KK, Dailey PJ, Tarara RP, Canfield DR, Aguirre NL, Cherrington JM, Lamy PD, Bischofberger N, Pedersen NC, Marthas ML.

J Virol. 1999 Apr;73(4):2947-55.

33.

Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques.

Baba TW, Liska V, Khimani AH, Ray NB, Dailey PJ, Penninck D, Bronson R, Greene MF, McClure HM, Martin LN, Ruprecht RM.

Nat Med. 1999 Feb;5(2):194-203. Erratum in: Nat Med 199 May;5(5):590.

PMID:
9930868
34.

Quantification of HCV RNA in Liver Tissue by bDNA Assay.

Dailey PJ, Collins ML, Urdea MS, Wilber JC.

Methods Mol Med. 1999;19:119-29. doi: 10.1385/0-89603-521-2:119.

PMID:
21374354
35.

Rapid clearance of simian immunodeficiency virus particles from plasma of rhesus macaques.

Zhang L, Dailey PJ, He T, Gettie A, Bonhoeffer S, Perelson AS, Ho DD.

J Virol. 1999 Jan;73(1):855-60.

36.

Sequential serum hepatitis C viral RNA levels longitudinally assessed by branched DNA signal amplification.

Gordon SC, Dailey PJ, Silverman AL, Khan BA, Kodali VP, Wilber JC.

Hepatology. 1998 Dec;28(6):1702-6. Erratum in: Hepatology 1999 Feb;29(2):616.

PMID:
9828238
37.

In vitro infection of primate PBMC with simian/human immunodeficiency virus, SHIV(SF33A): correlation to in vivo outcome.

Harouse JM, Tan RC, Gettie A, Dailey P, Marx PA, Luciw PA, Cheng-Mayer C.

J Med Primatol. 1998 Apr-Jun;27(2-3):81-6.

PMID:
9747947
38.

Quantification of cytokine mRNA in peripheral blood mononuclear cells using branched DNA (bDNA) technology.

Shen LP, Sheridan P, Cao WW, Dailey PJ, Salazar-Gonzalez JF, Breen EC, Fahey JL, Urdea MS, Kolberg JA.

J Immunol Methods. 1998 Jun 1;215(1-2):123-34.

PMID:
9744754
39.

Mucosal transmission of pathogenic CXCR4-utilizing SHIVSF33A variants in rhesus macaques.

Harouse JM, Tan RC, Gettie A, Dailey P, Marx PA, Luciw PA, Cheng-Mayer C.

Virology. 1998 Aug 15;248(1):95-107.

40.

Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.

Connor RI, Montefiori DC, Binley JM, Moore JP, Bonhoeffer S, Gettie A, Fenamore EA, Sheridan KE, Ho DD, Dailey PJ, Marx PA.

J Virol. 1998 Sep;72(9):7501-9.

41.

Hematologic and virologic effects of lineage-specific and non-lineage-specific recombinant human and rhesus cytokines in a cohort of SIVmac239-infected macaques.

Bucur SZ, Lackey DA 3rd, Adams JW, Lee ME, Villinger F, Mayne A, Bray RA, Winton EF, Novembre F, Strobert EA, De Rosayro J, Dailey PJ, Ansari AA, Hillyer CD.

AIDS Res Hum Retroviruses. 1998 May 20;14(8):651-60.

PMID:
9618076
42.

Distribution of brain HIV load in AIDS.

Wiley CA, Soontornniyomkij V, Radhakrishnan L, Masliah E, Mellors J, Hermann SA, Dailey P, Achim CL.

Brain Pathol. 1998 Apr;8(2):277-84.

PMID:
9546286
43.
44.

A genetic and viral load analysis of the simian immunodeficiency virus during the acute phase in macaques inoculated by the vaginal route.

Sodora DL, Lee F, Dailey PJ, Marx PA.

AIDS Res Hum Retroviruses. 1998 Jan 20;14(2):171-81.

PMID:
9462928
46.

Correlation of virus load in plasma and lymph node tissue in human immunodeficiency virus infection. INCAS Study Group. Italy, Netherlands, Canada, Australia, and (United) States.

Harris M, Patenaude P, Cooperberg P, Filipenko D, Thorne A, Raboud J, Rae S, Dailey P, Chernoff D, Todd J, Conway B, Montaner JS.

J Infect Dis. 1997 Nov;176(5):1388-92.

PMID:
9359745
47.

Effects of (R)-9-(2-phosphonylmethoxypropyl)adenine monotherapy on chronic SIV infection in macaques.

Tsai CC, Follis KE, Beck TW, Sabo A, Bischofberger N, Dailey PJ.

AIDS Res Hum Retroviruses. 1997 May 20;13(8):707-12.

PMID:
9168239
48.

Hepatitis C virus: quantitation and distribution in liver.

Terrault NA, Dailey PJ, Ferrell L, Collins ML, Wilber JC, Urdea MS, Bhandari BN, Wright TL.

J Med Virol. 1997 Mar;51(3):217-24.

PMID:
9139087
49.

Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239.

Miller CJ, McChesney MB, Lü X, Dailey PJ, Chutkowski C, Lu D, Brosio P, Roberts B, Lu Y.

J Virol. 1997 Mar;71(3):1911-21.

50.

Quantitative image analysis of HIV-1 infection in lymphoid tissue.

Haase AT, Henry K, Zupancic M, Sedgewick G, Faust RA, Melroe H, Cavert W, Gebhard K, Staskus K, Zhang ZQ, Dailey PJ, Balfour HH Jr, Erice A, Perelson AS.

Science. 1996 Nov 8;274(5289):985-9.

PMID:
8875941

Supplemental Content

Loading ...
Support Center